A simulation-based procedure to estimate base rates from Covid-19 antibody test results I: Deterministic test reliabilities
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
We design a procedure ( the complete Python code may be obtained at https://github.com/abhishta91/antibody_montecarlo ) using Monte Carlo (MC) simulation to establish the point estimators described below and confidence intervals for the base rate of occurence of an attribute (e.g., antibodies against Covid-19) in an aggregate population (e.g., medical care workers) based on a test. The requirements for the procedure are the test’s sample size ( N ) and total number of positives ( X ), and the data on test’s reliability.
The modus is the prior which generates the largest frequency of observations in the MC simulation with precisely the number of test positives (maximum-likelihood estimator). The median is the upper bound of the set of priors accounting for half of the total relevant observations in the MC simulation with numbers of positives identical to the test’s number of positives.
-
The median and the confidence intervals suffice universally.
-
The estimator may be outside of the two-sided 95% confidence interval.
-
Conditions such that the modus, the median and another promising estimator which takes the reliability of the test into account, are quite close.
-
Conditions such that the modus and the latter estimator must be regarded as logically inconsistent.
-
Conditions inducing rankings among various estimators relevant for issues concerning over-or underestimation.
Our rather preliminary findings are
JEL-codes: C11, C13, C63
Article activity feed
-
SciScore for 10.1101/2020.04.28.20075036: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: Thank you for sharing your code.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when …
SciScore for 10.1101/2020.04.28.20075036: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: Thank you for sharing your code.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
